News and Reports
 
  - 
  Delenex Presents Clinical Data on Topical Application of PENTRABodies2 September 2014Download
- 
  CardiacAssist Receives FDA Clearance for PROTEK Cannula28 August 2014Download
- 
  Ellipse Technologies? Revolutionary Spinal Deformity Treatment for Children on Display at IMAST this Week17 July 2014Download
- 
  HOYA and i-Optics enter into global partnership with novel eye care test for consumers14 July 2014Download
- 
  Pacira Pharmaceuticals, Inc. Announces Publication of Pooled Results from IMPROVE Studies Evaluating Health Economic Benefits of EXPAREL®26 June 2014Download
- 
  Basilea’s oncology drug candidate BAL101553 shows first evidence of antitumor activity in phase 1 study2 June 2014Download
- 
  PTC Therapeutics receives positive opinion from CHMP for Translarna? (ATALUREN)23 May 2014Download
- 
  Ophthotech Corporation Announces Closing of Registered Public Offering of Common Stock Including Full Exercise of Underwriters? Option to Purchase Additional Shares19 May 2014Download
- 
  Enanta Pharmaceuticals Announces Submission of EU Marketing Authorization Applications to the European Medicines Agency for All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-4508 May 2014Download
- 
  Pacira Pharmaceuticals, Inc. Announces sNDA Submission for EXPAREL Nerve Block Indication7 May 2014Download
- 
  Curetis Launches Unyvero™ i60 Implant and Tissue Infection Cartridge in Europe7 May 2014Download
- 
  New Favorable Clinical Evaluation Data for Unyvero™ P50 Pneumonia Application23 April 2014Download
- 
  Enanta Pharmaceuticals Announces New Drug Application Submission to the U.S. FDA for All-Oral, Interferon-Free Hepatitis C Regimen22 April 2014Download
- 
  Revolutionary Spinal Deformity Surgical Treatment is Available in the United States7 March 2014Download
- 
  Advanced Accelerator Applications enters UK and Irish nuclear medicine markets with the acquisition of Imaging Equipment Ltd4 March 2014Download
- 
  Basilea swaps its isavuconazole North American copromote rights for full isavuconazole rights outside of North America28 February 2014Download
- 
  Pacira Pharmaceuticals, Inc. Announces EXPAREL Phase 3 Clinical Trial in Femoral Nerve Block Meets Primary Efficacy Endpoint27 February 2014Download
- 
  PTC Therapeutics Announces Closing of Registered Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares19 February 2014Download
- 
  Option to Purchase Additional Shares Offering of Common Stock Including Full Exercise of Underwriters? Option to Purchase Additional Shares18 February 2014Download
- 
  PTC - Joint program in spinal muscular atrophy enters first stage of clinical development22 January 2014Download
- 
  Ophthotech closes initial public offering30 September 2013Download
- 
  Basilea reports positive topline phase 3 results for antifungal isavuconazole30 September 2013Download
- 
  Nabriva Therapeutics presented data on potency, safety, tolerability and pharmacokinetics of Pleuromutilin antibiotic BC-378113 September 2013Download
- 
  Tensys Medical receives CE Mark for TL-400 & TL-300, latest generations in continuous, non-invasive hemodynamic patient monitoring system3 September 2013Download
- 
  Ophthotech enrolls first patient in phase 3 clinical trial of Fovista™ Anti-PDGF therapy in combination with Anti-VEGF therapy for wet AMD29 August 2013Download